409 related articles for article (PubMed ID: 11380492)
1. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee GH; Mathias DB; James RA; Kendall-Taylor P
Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492
[TBL] [Abstract][Full Text] [Related]
2. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
3. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
[TBL] [Abstract][Full Text] [Related]
5. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.
Shimon I; Ram Z; Cohen ZR; Hadani M
Neurosurgery; 2002 Jul; 51(1):57-61; discussion 61-2. PubMed ID: 12182435
[TBL] [Abstract][Full Text] [Related]
6. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
[TBL] [Abstract][Full Text] [Related]
7. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
[TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome.
Arnott RD; Pestell RG; McKelvie PA; Henderson JK; McNeill PM; Alford FP
Acta Endocrinol (Copenh); 1990 Oct; 123(4):423-30. PubMed ID: 2173325
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission.
Rees DA; Hanna FW; Davies JS; Mills RG; Vafidis J; Scanlon MF
Clin Endocrinol (Oxf); 2002 Apr; 56(4):541-51. PubMed ID: 11966748
[TBL] [Abstract][Full Text] [Related]
10. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Estrada J; Boronat M; Mielgo M; Magallón R; Millan I; Díez S; Lucas T; Barceló B
N Engl J Med; 1997 Jan; 336(3):172-7. PubMed ID: 8988897
[TBL] [Abstract][Full Text] [Related]
11. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease.
McCance DR; Gordon DS; Fannin TF; Hadden DR; Kennedy L; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 1993 Jan; 38(1):79-86. PubMed ID: 8382119
[TBL] [Abstract][Full Text] [Related]
12. Early repeat surgery for persistent Cushing's disease.
Ram Z; Nieman LK; Cutler GB; Chrousos GP; Doppman JL; Oldfield EH
J Neurosurg; 1994 Jan; 80(1):37-45. PubMed ID: 8271020
[TBL] [Abstract][Full Text] [Related]
13. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome.
Weber A; Trainer PJ; Grossman AB; Afshar F; Medbak S; Perry LA; Plowman PN; Rees LH; Besser GM; Savage MO
Clin Endocrinol (Oxf); 1995 Jul; 43(1):19-28. PubMed ID: 7641408
[TBL] [Abstract][Full Text] [Related]
14. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.
Patil CG; Prevedello DM; Lad SP; Vance ML; Thorner MO; Katznelson L; Laws ER
J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770
[TBL] [Abstract][Full Text] [Related]
15. Predicting relapse after transsphenoidal surgery for Cushing's disease.
Toms GC; McCarthy MI; Niven MJ; Orteu CH; King TT; Monson JP
J Clin Endocrinol Metab; 1993 Feb; 76(2):291-4. PubMed ID: 8432771
[TBL] [Abstract][Full Text] [Related]
16. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
Trainer PJ; Lawrie HS; Verhelst J; Howlett TA; Lowe DG; Grossman AB; Savage MO; Afshar F; Besser GM
Clin Endocrinol (Oxf); 1993 Jan; 38(1):73-8. PubMed ID: 8435888
[TBL] [Abstract][Full Text] [Related]
17. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease.
Ohnishi T; Arita N; Yoshimine T; Mori S
Acta Neurochir (Wien); 2000; 142(8):855-64. PubMed ID: 11086823
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cure and recurrence after pituitary surgery for Cushing's disease.
Barbetta L; Dall'Asta C; Tomei G; Locatelli M; Giovanelli M; Ambrosi B
Acta Neurochir (Wien); 2001; 143(5):477-81; discussion 481-2. PubMed ID: 11482698
[TBL] [Abstract][Full Text] [Related]
19. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of early prognostic factors for risk of treatment failure in Cushing's disease treated by trans-sphenoidal pituitary surgery].
Martino J; Acebes JJ; Montanya E; Masuet C; Brell M
Med Clin (Barc); 2007 Mar; 128(9):330-2. PubMed ID: 17376359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]